$1.69
Today
as of Sep 4, 16:49 ET
Last 30 days
Recent Press Releases & News
Health Catalyst to Participate in Upcoming Investor Conference
Health Catalyst Shares Fall After Canaccord Genuity Downgrade
Canaccord Genuity Downgrades Health Catalyst to Hold From Buy, Adjusts Price Target to $1.80 From $3
Overview
52-week range
$0.95
$3.62
28% of range
Avg surprise (last 3)
+35.4%
Avg reaction (last 2)
-5.8%
0% positive
Latest IV / EM
567%
EM ±94.7% · $3 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.55 | — | — | — | — | financials |
| Mon May 11, 2026 | Mar/2026 | $-0.03 | $-0.09 | +66.7% | +70.0% | -9.2% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.32 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-0.08 | $-0.09 | +11.1% | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $-0.10 | $-0.14 | +28.6% | — | -2.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.24 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.23 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.35 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.39 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.58 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.60 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $70M | $71M | — | $76M | $81M | $79M | — | $76M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | $40M | — | — | — | $36M |
| Operating income | $-36M | $-106M | — | $-18M | $-37M | $-20M | — | $-14M |
| Net income | $-41M | $-111M | — | $-22M | $-41M | $-24M | — | $-15M |
| EPS (diluted) | $-0.55 | $-1.53 | — | $-0.32 | $-0.59 | $-0.35 | — | $-0.24 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $61M | $60M | $51M | $40M | $51M | $342M | $250M | $328M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $248M | $182M | $169M | $165M | $181M | $423M | $466M | $457M |
| Total assets | $359M | $412M | $503M | $587M | $616M | $892M | $859M | $813M |
| Long-term debt | $152M | $152M | $152M | $152M | $151M | $151M | $151M | $115M |
| Total liabilities | $258M | $274M | $257M | $255M | $269M | $515M | $494M | $458M |
| Total equity | $101M | $138M | $246M | $332M | $348M | $377M | $365M | $355M |